World Nutrition Announces Highly Active Enzyme Therapy to be Offered Exclusively Through Healthcare
World Nutrition, Inc., a leader in the development of therapeutic nutritional supplements, today announced the release of Vitälzym X, a “prescription-strength” version of its industry-leading Vitälzym enzyme therapy product. Unlike other mass-distributed enzyme supplements, Vitälzym X is available to the public only from licensed healthcare professionals.
“Vitälzym X is based on the same great formula that has made Vitälzym the leading product in systemic enzyme therapy,” said World Nutrition vice president Jeffrey Pataky. “We’ve added our own unique blend of the enzyme protease to enable the powerful ingredients in Vitälzym X to withstand the harsh acidic climate that exists in the stomach. This increases the product’s overall activity rate and makes Vitälzym X far more effective than other supplements used to help sufferers of rheumatoid arthritis, fibromyalgia, acute pain, and other chronic conditions.”
Early laboratory and field tests have produced remarkable results, recalled World Nutrition chief operating officer David Harrington. “Our studies have shown the activity rate of Vitälzym X to be significantly better than the nearest enzyme product,” Harrington said.
Vitälzym X was created at the request of World Nutrition’s healthcare practitioner clients, and several physicians played an integral role in its development, added Pataky. “Vitälzym X is but the first in the family of products we’re planning exclusively for healthcare professionals,” Pataky said. “Our primary goal is to continually provide the products and services doctors need to offer their patients relief through natural and alternative therapies.”
Article Pages: 1
Article CommentsAdd Comment |
View All(0)
There are currently no comments for this article.